Skip to content

Drug interactions

Finerenone + Midazolam

Severity: Minor

Finerenone and Midazolam: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Midazolam is a weak CYP3A4 inhibitor and may modestly raise finerenone exposure, increasing the risk of hyperkalemia. The effect is usually small, with single midazolam doses.

What this interaction means in plain words

Finerenone and Midazolam have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Finerenone belongs to Cardiovascular; Midazolam belongs to Central Nervous System.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition by midazolam reduces finerenone metabolism.

What to do

Monitor serum potassium when midazolam is used repeatedly with finerenone and adjust finerenone dosing if hyperkalemia develops.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Finerenone and Midazolam, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Finerenone with Midazolam?

MediHelp rates the interaction as minor. Finerenone and Midazolam have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Midazolam is a weak CYP3A4 inhibitor and may modestly raise finerenone exposure, increasing the risk of hyperkalemia. The effect is usually small, with single midazolam doses.

How serious is the interaction between Finerenone and Midazolam?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium when midazolam is used repeatedly with finerenone and adjust finerenone dosing if hyperkalemia develops.

What other medicines interact with Midazolam?

MediHelp also lists interactions of Midazolam with, for example, Atazanavir, Cobicistat, Darunavir. The full list is on the Midazolam page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in